High-pressure homogenisation enhances the physicochemical performance, stability and anticancer activity of Zn(DDC) 2 -loaded liposomes

Zinc diethyldithiocarbamate (Zn(DDC)2) is a lipophilic metal–dithiocarbamate complex with anticancer potential, but poor aqueous solubility limits its pharmaceutical development. This study compared high-pressure homogenisation (HPH) and probe sonication for preparing Zn(DDC)2-loaded liposomes and evaluated their effects on formulation performance, stability and cytotoxicity. Liposomes composed of hydrogenated soy phosphatidylcholine, cholesterol and Zn(DDC)2 were prepared at molar ratios of 45:45:10 and 60:30:10, processed by HPH or probe sonication, and characterised for particle size, PDI, zeta potential, encapsulation efficiency, pH, osmolality, release, 28-day stability and A549 cytotoxicity. HPH produced smaller vesicles (178.0 ± 11.1 and 179.7 ± 15.2 nm), higher-magnitude zeta potentials (−16.4 ± 0.5 and −21.4 ± 1.6 mV), improved encapsulation efficiency and more sustained release than probe sonication. The optimised HPH formulation released 81.4 ± 3.9% Zn(DDC)2 over 24 h compared with 98.3 ± 1.4% from the corresponding sonicated formulation. HPH liposomes also maintained greater physicochemical stability over 28 days. In A549 cells, HPH liposomes showed significantly greater cytotoxicity (IC50 = 3.82 ± 0.75 µM) than sonicated liposomes (7.68 ± 2.51 µM) and free Zn(DDC)2 (54.63 ± 1.59 µM) (p < 0.05). These findings support HPH as a scalable platform for Zn(DDC)2 liposomal delivery and underline the importance of manufacturing process selection in optimising liposomal anticancer formulations.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Development and Technology
Published
2026-11-18
DOI
https://doi.org/10.1080/10837450.2026.2762195
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

High-pressure homogenisation enhances the physicochemical performance, stability and anticancer activity of Zn(DDC) 2 -loaded liposomes

Sahrish Rehmani, Mohammad Najlah, Mouhamad Khoder, Ayşe Kaya et al.
1 links
Pharmaceutical Development and Technology
Nanoparticle-Based Drug Delivery
article

High-pressure homogenisation enhances the physicochemical performance, stability and anticancer activity of Zn(DDC) 2 -loaded liposomes

Sahrish Rehmani, Mohammad Najlah, Mouhamad Khoder, Ayşe Kaya, Irfan Bashir
article en

Abstract

Zinc diethyldithiocarbamate (Zn(DDC)2) is a lipophilic metal–dithiocarbamate complex with anticancer potential, but poor aqueous solubility limits its pharmaceutical development. This study compared high-pressure homogenisation (HPH) and probe sonication for preparing Zn(DDC)2-loaded liposomes and evaluated their effects on formulation performance, stability and cytotoxicity. Liposomes composed of hydrogenated soy phosphatidylcholine, cholesterol and Zn(DDC)2 were prepared at molar ratios of 45:45:10 and 60:30:10, processed by HPH or probe sonication, and characterised for particle size, PDI, zeta potential, encapsulation efficiency, pH, osmolality, release, 28-day stability and A549 cytotoxicity. HPH produced smaller vesicles (178.0 ± 11.1 and 179.7 ± 15.2 nm), higher-magnitude zeta potentials (−16.4 ± 0.5 and −21.4 ± 1.6 mV), improved encapsulation efficiency and more sustained release than probe sonication. The optimised HPH formulation released 81.4 ± 3.9% Zn(DDC)2 over 24 h compared with 98.3 ± 1.4% from the corresponding sonicated formulation. HPH liposomes also maintained greater physicochemical stability over 28 days. In A549 cells, HPH liposomes showed significantly greater cytotoxicity (IC50 = 3.82 ± 0.75 µM) than sonicated liposomes (7.68 ± 2.51 µM) and free Zn(DDC)2 (54.63 ± 1.59 µM) (p < 0.05). These findings support HPH as a scalable platform for Zn(DDC)2 liposomal delivery and underline the importance of manufacturing process selection in optimising liposomal anticancer formulations.

Pharmaceutical Development and Technology
Kingston University London (GB), Kingston University (US), Anglia Ruskin University (GB)
Anglia Ruskin University, Innovate UK
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon